Hu Y - Search Results

1

Covalently combining carbon nanotubes with anticancer agent: preparation and antitumor activity.

Wu W, Li R, Bian X, Zhu Z, Ding D, Li X, Jia Z, Jiang X, Hu Y. Wu W, et al. Among authors: hu y. ACS Nano. 2009 Sep 22;3(9):2740-50. doi: 10.1021/nn9005686. ACS Nano. 2009. PMID: 19702292

2

Surface-potential-regulated transmembrane and cytotoxicity of chitosan/gold hybrid nanospheres.

Ding Y, Bian X, Yao W, Li R, Ding D, Hu Y, Jiang X, Hu Y. Ding Y, et al. Among authors: hu y. ACS Appl Mater Interfaces. 2010 May;2(5):1456-65. doi: 10.1021/am1001019. ACS Appl Mater Interfaces. 2010. PMID: 20420367

3

The role of adhesions between homologous cancer cells in tumor progression and targeted therapy.

Xia J, Cheng Y, Zhang H, Li R, Hu Y, Liu B. Xia J, et al. Among authors: hu y. Expert Rev Anticancer Ther. 2017 Jun;17(6):517-526. doi: 10.1080/14737140.2017.1322511. Epub 2017 May 2. Expert Rev Anticancer Ther. 2017. PMID: 28447483 Review.

4

Tumor Oxygenation and Hypoxia Inducible Factor-1 Functional Inhibition via a Reactive Oxygen Species Responsive Nanoplatform for Enhancing Radiation Therapy and Abscopal Effects.

Meng L, Cheng Y, Tong X, Gan S, Ding Y, Zhang Y, Wang C, Xu L, Zhu Y, Wu J, Hu Y, Yuan A. Meng L, et al. Among authors: hu y. ACS Nano. 2018 Aug 28;12(8):8308-8322. doi: 10.1021/acsnano.8b03590. Epub 2018 Aug 15. ACS Nano. 2018. PMID: 30102510

5

Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy.

Ding D, Tang X, Cao X, Wu J, Yuan A, Qiao Q, Pan J, Hu Y. Ding D, et al. Among authors: hu y. AAPS PharmSciTech. 2014 Feb;15(1):213-22. doi: 10.1208/s12249-013-0041-3. Epub 2013 Nov 28. AAPS PharmSciTech. 2014. PMID: 24287627 Free PMC article.

6

Zoledronic Acid-Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment.

Huang Z, Yao D, Ye Q, Jiang H, Gu R, Ji C, Wu J, Hu Y, Yuan A. Huang Z, et al. Among authors: hu y. ACS Nano. 2021 May 25;15(5):8450-8465. doi: 10.1021/acsnano.0c10764. Epub 2021 May 3. ACS Nano. 2021. PMID: 33938751

7

E. coli Membrane Vesicles as a Catalase Carrier for Long-Term Tumor Hypoxia Relief to Enhance Radiotherapy.

Zai W, Kang L, Dong T, Wang H, Yin L, Gan S, Lai W, Ding Y, Hu Y, Wu J. Zai W, et al. Among authors: hu y. ACS Nano. 2021 Sep 28;15(9):15381-15394. doi: 10.1021/acsnano.1c07621. Epub 2021 Sep 14. ACS Nano. 2021. PMID: 34520168

8

Replacing heme with paclitaxel to prepare drug-loaded globin nanoassembles for CD163 targeting.

Meng Z, Yang X, Hu D, Wang K, Zhi F, Chen X, Gong G, Wu J, Hu Y. Meng Z, et al. Among authors: hu d, hu y. J Pharm Sci. 2015 Mar;104(3):1045-55. doi: 10.1002/jps.24290. Epub 2015 Jan 14. J Pharm Sci. 2015. PMID: 25640195

9

Self-assembled albumin nanoparticles for combination therapy in prostate cancer.

Lian H, Wu J, Hu Y, Guo H. Lian H, et al. Among authors: hu y. Int J Nanomedicine. 2017 Oct 24;12:7777-7787. doi: 10.2147/IJN.S144634. eCollection 2017. Int J Nanomedicine. 2017. PMID: 29123392 Free PMC article.

10

Combining High-Z Sensitized Radiotherapy with CD73 Blockade to Boost Tumor Immunotherapy.

Chen Q, Chen J, Zhang Q, Yang P, Gu R, Ren H, Dai Y, Huang S, Wu J, Wu X, Hu Y, Yuan A. Chen Q, et al. Among authors: hu y. ACS Nano. 2023 Jul 11;17(13):12087-12100. doi: 10.1021/acsnano.2c11403. Epub 2023 Jun 16. ACS Nano. 2023. PMID: 37327456

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48,267 results

Search Page

Filters